Moderna Shares Surged 20% on Coronavirus Vaccine Data. Here's What May Drive Them Higher.

Moderna Shares Surged 20% on Coronavirus Vaccine Data. Here's What May Drive Them Higher.

Motley Fool

Published

Moderna’s initial coronavirus vaccine results are promising -- but confirmation in more trial participants is key.

Full Article